← Back to Analyst Consensus 
PTGX Buy
Protagonist Therapeutics, Inc
Current Price —
Implied Upside —
Analysts 20
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 1 reiterations from 2 firms
Next Earnings
Nov 4, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Oct 12, 2026 | UBS | initiate | — → Buy | — | 54% |
| Sep 1, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Sep 1, 2026 | BMO Capital | maintain | Outperform → Outperform | — | 53% |
| Aug 31, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Aug 31, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 17, 2026 | BMO Capital | maintain | Outperform → Outperform | — | 53% |
| Aug 10, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Aug 10, 2026 | Wedbush | maintain | Outperform → Outperform | — | 57% |
| Aug 10, 2026 | Goldman Sachs | upgrade | Neutral → Buy | — | 54% |
| Aug 6, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Aug 6, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 14, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| May 10, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 6, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 48% |
| May 6, 2026 | Wedbush | maintain | Outperform → Outperform | — | 57% |
| Apr 15, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Apr 7, 2026 | Clear Street | maintain | Buy → Buy | — | 47% |
| Mar 19, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Mar 19, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Mar 19, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 19, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Mar 3, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Feb 26, 2026 | TD Cowen | maintain | Buy → Buy | $100 | 54% |
| Feb 26, 2026 | Barclays | maintain | Overweight → Overweight | $113 | 53% |
| Feb 26, 2026 | Citizens | maintain | Market Outperform → Market Outperform | $112 | 48% |
| Feb 2, 2026 | Jefferies | maintain | Buy → Buy | $118 | 52% |
| Jan 30, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $117 | 44% |
| Jan 5, 2026 | Truist Securities | maintain | Buy → Buy | $110 | 54% |
| Dec 17, 2025 | Barclays | maintain | Overweight → Overweight | $108 | 53% |
| Dec 8, 2025 | Citigroup | maintain | Buy → Buy | $115 | 54% |
| Nov 10, 2025 | Citigroup | maintain | Buy → Buy | $98 | 54% |
| Nov 7, 2025 | JP Morgan | maintain | Overweight → Overweight | $81 | 55% |
| Nov 7, 2025 | Barclays | maintain | Overweight → Overweight | $88 | 53% |
| Nov 7, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $102 | 48% |
| Oct 28, 2025 | Truist Securities | maintain | Buy → Buy | $88 | 54% |
| Oct 28, 2025 | Wedbush | maintain | Outperform → Outperform | $86 | 57% |
| Oct 28, 2025 | BTIG | reiterate | Buy → Buy | $82 | 52% |
| Oct 17, 2025 | Citigroup | maintain | Buy → Buy | $96 | 54% |
| Oct 8, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Sep 17, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Sep 17, 2025 | Barclays | initiate | — → Overweight | $72 | 53% |
| Sep 12, 2025 | Leerink Partners | initiate | — → Outperform | $73 | 51% |
| Aug 7, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $69 | 53% |
| Jun 17, 2025 | Citigroup | initiate | — → Buy | $72 | 54% |
| Jun 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| May 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Apr 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Mar 28, 2025 | Wedbush | reiterate | Outperform → Outperform | $70 | 57% |
Price Target Trend
Jul 17, 2026 Oct 27, 2026
EPS Estimates
0y —
+1y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days